Delisting Determination,The Nasdaq Stock Market, LLC,
November 24, 2015, Oncolytics Biotech, Inc. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Oncolytics Biotech, Inc.
(the Company), effective at the opening of the
trading session on December 4, 2015. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(a)(2).
The Company was notified of the Staffs determination on
October 27, 2015. The Company did not appeal the Staff
determination to the Hearings Panel, and the Staff
determination to delist the Company became final on
November 5, 2015.